New Fogarty Company Addresses $1.75 Billion Chronic Sinusitis Market

Imagine having a really bad cold that never goes away—congestion, runny nose, facial pressure, headache and loss of smell for more than three months. That’s what it feels like to the more than 36 million people in the U.S. who suffer from chronic rhinosinusitis (CRS), a persistent inflammatory condition of the nasal and sinus cavity lining.

START TYPING AND PRESS ENTER TO SEARCH